Search

everythinglearnresearchcommunity

for

Search:↓

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Mast cells and VEGF contribute to post-surgery adhesions, and blocking VEGF can reduce these adhesions; also, certain factors affect wound healing and fetal skin heals differently with age.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Injections improve hair growth, density, and thickness in women safely.

Scientists made stem cells that can grow hair by adding three specific factors to them.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

Lasers can help reduce skin side effects from cancer treatment.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.